<unk>  is an oral hypoglycemic that is FDA approved for the treatment of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia,  nausea, epigastric fullness, heartburn,  pruritus, erythema, urticaria, leukopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, aplastic anemia.
Tolazamide
Betanidine
Levodropropizine
Midazolam 
Dropropizine
Dexmedetomidine
Ketazolam
Pantethine